Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial

Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial

Abstract Background In Australia, tobacco smoking rates have declined but inequalities remain with significantly higher smoking prevalence among low-socioeconomic populations. Clinical trial data suggest vaporized nicotine products (VNPs) aid smoking cessation. Most VNP trials have used refillable t...

Full description

Bibliographic Details
Main Authors: Bridget C Howard, Hayden McRobbie, Dennis Petrie, Daniel Barker, Colin Mendelsohn, Jack Anderson, Ron Borland, Felix Naughton, Piotr Tutka, Nick Zwar, Veronica C Boland, Alexandra Aiken, Anthony Shakeshaft, Coral Gartner, Robyn L Richmond, Wayne Hall, Richard P Mattick, Michael Farrell, Ryan J Courtney
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Trials
Subjects:
Cost-effectiveness
Electronic cigarettes
Randomized controlled trial
Smoking cessation
Social disadvantage
Tobacco
Online Access:https://doi.org/10.1186/s13063-022-06644-8

Internet

https://doi.org/10.1186/s13063-022-06644-8

Similar Items